Global PDE Inhibitors Market by Application (Erectile Dysfunction, Cardiovascular Disease, Benign Prostate Hyperplasia, Respiratory Disease, Neurological Diseases, Dermatological Disorders, Pulmonary Hypertension, Others), by Drug Class (PDE-1, PDE-2, PDE-3, PDE-4, PDE-5, Viagra, Cialis, Levitra, Others), by Region – Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2017–2022)
Global PDE Inhibitors Market Revenue Forecasts 2017 to 2022.
Global PDE Inhibitors market, PDE Inhibitors market size, PDE Inhibitors market share, PDE Inhibitors brands, PDE Inhibitors price, PDE Inhibitors market growth, PDE Inhibitors market investment.
Global PDE Inhibitors Market size is set on a high growth trajectory and the growth is looking promising during the forecast period.
The Global PDE Inhibitors market size was approximately USD XX million in 2017 and showing a huge increase with a CAGR of XX% and is anticipated to reach USD XX million by 2022.
The high sales and market growth of PDE-5 have encouraged pharmaceutical manufacturers to invest more money in further research of PDE Inhibitors market. This is expected to be a key driving factor of the market. Increasing awareness of people towards usage of PDE Inhibitors is propelling the market size.
The PDE Inhibitors market is segmented by Application and by Drug Type. By Application, the market is categorized into Erectile Dysfunction, Cardiovascular Disease, Benign Prostate Hyperplasia, Respiratory Disease, Neurological Diseases, Dermatological Disorders, Pulmonary Hypertension, Others. By Drug type, the market is further divided into PDE-1, PDE-2, PDE-3, PDE-4, PDE-5, Viagra, Cialis, Levitra, and others. The increasing demand for PDE-5 from the pediatric patients suffering from Pulmonary Hypertension has helped it to occupy the major market share. Besides, PDE-5 can also be used to treat patients suffering from erectile dysfunction and minor heart attacks, this can further fuel the market size. From the recent studies, we can easily conclude that PDE-5 can be safely suggested to infants and children suffering from Pulmonary Hypertension which can also be attributed to increasing the size of the PDE Inhibitors market. The PDE-4 inhibitor which is used in treating atopic dermatitis and skin disorders is also expected to increase its demand as some of its key manufacturers received FDA approval regarding its production.
By geography, the market is segmented into Latin America, Asia Pacific, Europe, North America, and Middle East and Africa. Currently, North America occupies a major share of global market owing to the presence of key players and increasing demand for the PDE Inhibitors. In developing countries like India and China, the market is showing a considerable rise in the past few years and looking forward to increasing furthermore in coming years.
Some of the major manufacturers in the PDE Inhibitors Market are Mist Pharmaceuticals, AstraZeneca, Nusirt Biopharma, Takeda Pharmaceuticals, Bayer AG, Pfizer, Otsuka, Eli Lilly, Verona Pharma, Omeros, Hanmi Science Holding, Celgene Corporation.